Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mitoxantrone
Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P3
BB
(66)
Muamycin
Anal Carcinoma
Federation Francophone de Cancerologie Digestive
P3
BB
(66)
Navacaprant
Major Depressive Disorder
Neumora Therapeutics, Inc.
P3
BB
(66)
Nivestim
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
BB
(66)
Nivestim
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
Nivestim
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
BB
(66)
Nivestim
Hodgkins Lymphoma
Thomas Jefferson University
P3
BB
(66)
Nivestim
Plasma Cell Neoplasm
Hellenic Society of Hematology
P3
BB
(66)
Nivestim
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer Center
P3
BB
(66)
Nivestim
Smoldering Plasma Cell Myeloma
Regeneron Pharmaceuticals
P3
BB
(66)
Nivolumab
Lung Adenocarcinoma
Emory University
P3
BB
(66)
Nivolumab
Colorectal Neoplasm
Bristol-Myers Squibb
P3
BB
(66)
Nivolumab
Urethra Transitional Cell Carcinoma
Nagoya University
P3
BB
(66)
Nivolumab
Colon Adenocarcinoma
IFOM ETS - The AIRC Institute of Molecular Oncology
P3
BB
(66)
Nogitecan
Ovarian Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P3
BB
(66)
Nogitecan
Fallopian Tube Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
P3
BB
(66)
Nogitecan
Lung Cancer
Fox Chase Cancer Center
P3
BB
(66)
Non-Replicating Recombinant Self-Complementary (Sc) Adeno-Associated Virus Serotype 9 (Aav9) Vector Containing The Cdna Of The Survival Of Motor Neuron 2 (Smn2) Gene Under The Control Of The Hybrid Cytomegalovirus (Cmv) Enhancer/Chicken Beta-Actin Promoter (Cba)
Spinal Muscular Atrophy, Type 1
Novartis Gene Therapies
P3
BB
(66)
Obeticholic Acid
Primary Biliary Cholangitis
Intercept Pharmaceuticals
P3
BB
(66)
Ondansetron
Lymphoma
Fox Chase Cancer Center
P3
BB
(66)
Orelabrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(66)
Oxaliplatin
Breast Neoplasm
Kristina A. Fanucci
P3
BB
(66)
Oxaliplatin
Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
Oxaliplatin
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.
P3
BB
(66)
Oxaliplatin
Liver Cancer
Sun Yat-sen University
P3
BB
(66)
Showing 2276 to 2300 of 42,301 assets
Previous
Page 92 of 1693
Next